Physitrack figured out something that most digital health startups miss: the bottleneck in physical therapy is not the patient, it is the therapist. They built a platform that lets clinicians prescribe, track and communicate about exercise programs in minutes rather than hours. Over 100,000 healthcare professionals in 120+ countries use it, which is a distribution moat that is genuinely hard to replicate. It is a quiet, unsexy SaaS business — and that is exactly why it works.
Founded
2012
HQ
London, United Kingdom
Total Raised
$15 million
Founder
Henrik Molin and Will Agerholm
Status
Public (Nasdaq First North: PTRACK)
Website
www.physitrack.comTHE ORIGIN STORY
Henrik Molin, a Swedish entrepreneur, noticed that physiotherapists spent enormous time hand-drawing exercise diagrams and writing paper instructions for patients who then ignored them. Will Agerholm, an Australian with a healthcare background, joined to co-found the company in 2012.
They built a simple app that let clinicians prescribe video-guided exercises from a library of 3,000+ movements and track patient completion remotely. The product was so obviously useful that early clinical adoption happened with almost no marketing budget.
WHAT THEY ACTUALLY DO
SaaS subscription for healthcare professionals. Individual physios and clinicians pay a monthly or annual fee to access the platform.
Enterprise contracts cover large hospital systems and rehabilitation networks. Patients access the app for free — the clinician pays.
Revenue has grown steadily as the company expanded from physiotherapy into occupational therapy, sports medicine and corporate wellness.
THE PRODUCTS
[ "Physitrack Pro — the core exercise prescription and patient engagement platform for individual clinicians", "Physitrack Enterprise — white-label version for hospital systems and large rehabilitation networks", "PhysiApp — the patient-facing mobile app that delivers prescribed exercise programs with video guidance", "Physitrack Outcomes — data analytics module for tracking patient progress and clinical outcomes" ]
HOW THEY GREW
Land clinicians individually with a freemium-to-paid funnel, then expand into enterprise healthcare systems once clinical proof points accumulate. Geographic expansion has been the main growth driver — Physitrack operates in 120+ countries, with strong penetration in the UK, Australia, Scandinavia and North America.
The company listed on Nasdaq First North in Sweden in 2020, which provided capital for enterprise sales expansion.
THE HARD PART
Convincing large hospital systems to standardize on a single exercise prescription platform. Hospital IT procurement is slow and political, and Physitrack competes with in-house systems that clinicians have used for years.
The sales cycle for enterprise deals can stretch to 24 months, creating lumpy revenue recognition.
MONEY TRAIL
IPO (Nasdaq First North)
2020 · Led by Nordic Institutional Investors
$7M raised
WHO BACKED THEM
Physitrack is primarily founder-led and bootstrapped to profitability before its Nasdaq First North IPO in 2020. The IPO raised approximately SEK 65 million (roughly $6.5 million) from Nordic institutional investors.
The company does not have major venture capital backing.
Related Profiles
Companies
Headway
Headway and Physitrack are both infrastructure plays in healthcare — one for mental health therapists, the other for physiotherapists. Both bet that empowering the clinician with better tools is the fastest path to scale in a fragmented healthcare market.
Kaia Health
Both serve the digital musculoskeletal health market but from opposite ends. Physitrack equips clinicians with better tools, Kaia Health replaces clinical visits with AI-guided self-care. They are more complementary than competitive — Physitrack can run inside a hospital system, Kaia sits at the employer benefits layer.
Head-to-Head
Compare Physitrack vs another company.